United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of neomycin sulfate tablets, usp and other antibacterial drugs, neomycin sulfate tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. neomycin sulfate tablets are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel, eg, preoperative preparation of the bowel. it is given concomitantly with erythromycin enteric-coated base (see dosage and administration ). neomycin sulfate has been shown to be effective adjunctive therapy in hepatic coma by reduction of the ammonia-forming bacteria in the intestinal tract. the subsequent r

United States - English - NLM (National Library of Medicine)

breckenridge pharmaceutical, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin 350 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of neomycin sulfate tablets usp and other antibacterial drugs, neomycin sulfate tablets usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. suppression of intestinal bacteria:   neomycin sulfate tablets are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel, e.g., preoperative preparation of the bowel. it is given concomitantly with erythromycin enteric-coated base (see dosage and administration section). hepatic coma (portal-systemic encephalopathy):   neomycin sulfate has been shown to be effective adjunctive therapy in hepati

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin 3.5 mg in 1 g - for the treatment of corticosteroid-responsive dermatoses with secondary infection. it has not been demonstrated that this steroid-antibiotic combination provides greater benefit than the steroid component alone after 7 days of treatment. (see warnings.) not for use in the eyes or in the external ear canal if the eardrum is perforated. this product is contraindicated in tuberculous, fungal, or viral (for example, herpes simplex or varicella zoster) lesions of the skin. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

approved prescription services ltd - hydrocortisone acetate; neomycin sulfate - cutaneous cream - 10mg/1gram ; 5mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - hydrocortisone acetate; neomycin sulfate - cutaneous cream - 10mg/1gram ; 5mg/1gram

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - for the treatment of superficial bacterial infections of the external auditory canal caused by organisms susceptible to the action of the antibiotics. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components. this product should not be used if the external auditory canal disorder is suspected or known to be due to cutaneous viral infection (for example, herpes simplex virus or varicella zoster virus).

United States - English - NLM (National Library of Medicine)

medimetriks pharmaceuticals - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - neo-synalar® cream is indicated for the treatment of corticosteroid-responsive dermatoses with secondary infection. it has not been demonstrated that this steroid-antibiotic combination provides greater benefit than the steroid component alone after 7 days of treatment (see warnings section) . topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. this product should not be used in the external auditory canal if the eardrum is perforated.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - for the treatment of superficial bacterial infections of the external auditory canal caused by organisms susceptible to the action of the antibiotics. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components. this product should not be used if the external auditory canal disorder is suspected or known to be due to cutaneous viral infection (for example, herpes simplex virus or varicella zoster virus).

United States - English - NLM (National Library of Medicine)

a-s medication solutions - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - for the treatment of superficial bacterial infections of the external auditory canal caused by organisms susceptible to the action of the antibiotics, and for the treatment of infections of mastoidectomy and fenestration cavities caused by organisms susceptible to the antibiotics. this product is contraindicated in those individuals who have shown hypersensitivity to any of its components, and in herpes simplex, vaccinia, and varicella infections.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - neomycin as the sulfate - oral powder, pre-mix - neomycin as the sulfate antibiotic active 1000.0 g/kg - nutrition & metabolism - cattle | pigs | poultry | beef | boar | bos indicus | bos taurus | bovine | breeders | broiler | buffalo | bull | bullock | calf - bacterial enteritis | escherichia coli (e. coli) | proteus spp. | pseudomonas spp. | salmonella | including b-lactamase producin | post-weaning bacterial enterit | salmonellosis